# WELIREG

NDC: 0006-5331
Generic name: belzutifan
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20210813

FDA application: NDA215383

## Active ingredients

- BELZUTIFAN: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5331"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5331
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13e15ee0-d679-4fa9-9430-e2e2170474da